Viewing Study NCT04923932


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-01 @ 2:03 AM
Study NCT ID: NCT04923932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2021-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Sponsor: Hutchison Medipharma Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-27
Start Date Type: ACTUAL
Primary Completion Date: 2026-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12
Completion Date Type: ESTIMATED
First Submit Date: 2021-05-30
First Submit QC Date: None
Study First Post Date: 2021-06-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-20
Last Update Post Date: 2025-05-23
Last Update Post Date Type: ACTUAL